FMW Media’s New to The Street TV announces the broadcasting of its
business TV show, Saturday, August 7, 2021 on Bloomberg TV at 4:30
PM ET.
New to The Street’s TV line-up features the
following 5-Companies and their businesses representatives:
1). Tonix Pharmaceuticals, Inc.’s
(NASDAQ:TNXP) interview with Mr. Seth Lederman, CEO
2). Artificial Intelligence Technology Solutions,
Inc.’s (OTCPink:AITX) interview with Steven Reinharz, CEO.
3) RushNet, Inc.’s (a.k.a – heliosDX) (OTCPink:
RSHN) interview with Ashley Sweat, Chief Executive Officer /
Chairman.
4). GlobeX Data Ltd’s. (OTCQB:SWISF) (CSE:SWIS)
(FRA:GDT) interview with Mr. Alain Ghiai, CEO.
5) First Graphene Ltd.’s (OTCQB:FGPHF) interview
with Mr. Michael Bell, CEO.
Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP)
CEO, Seth Lederman, talks to New To The StreetTV about their
Company’s pharmaceutical products, and he leads a further in-depth
discussion about their development and FDA phase 3 trial on
its Fibromyalgia drug. Mr. Lederman talks about the importance
of ‘HOW’ their Fibromyalgia drug helps patients sleep better
without pain.
New to the Street TV show interviews Mr. Steven
Reinharz, CEO at Artificial Intelligence Technology Solutions, Inc.
(OTCPink: AITX) who talks to viewers about the Company and its
wholly-owned subsidiary, Robotic Assistance Devices, Inc. (RAD). He
gives very detailed description of its AI-driven security
analytical product, ROSA 180 (Responsive Observation Security
Agent). Mr. Reinharz provides numerous real use applications and
its successful roll-outs as a less expensive and efficient security
solution for a number of industries.
Ashely Sweat, CEO at RushNet, Inc.’s (a.k.a –
heliosDX) (OTCPink: RSHN) joins the New to The Street show. Mr.
Sweat explains RushNet, Inc.’s. (heliosDX) very sophisticated and
technological advanced clinical laboratory, which can provide
highly accurate tests for a variety of different medical and
clinical needs. Further, he outlines RSHN’s business model and the
expected growth associated with their lab platforms and its
uniqueness in the clinical lab industry sector.
Once again on New to The Street TV, Mr. Alain
Ghiai, CEO, GlobeX Data, Ltd (OTCQB:SWISF) (CSE:SWIS)
(FRA:GDT) who gives more pivotal information to viewers about
their business and their plans to grow the Company. As an
international acclaimed expert in internet security and privacy, he
provides in-depth discussion of the Company’s successful growth of
its secure and encrypted software solutions, SekurSafe® and
Sekur®. Alain reminds the viewers that GlobeX Data NEVER sells data
to third-parties. He gives very specific and interesting dialog
about keeping their clients’ business communications and data safe
while utilizing Swiss Privacy Laws.
New to The Street welcomes to the show Mr. Michael
Bell, CEO, First Graphene Ltd (OTCQB:FGPHF). Mr. Bell explains the
Company’s operations and graphene products. He talks about
PureGRAPH® as being recognized as a world leading graphene product
brand. Mr. Bell continues the interview with a discussion about
their graphene production, mining tonnage projections, and the
newly adoption of graphene in a variety of products used
worldwide.
About Tonix Pharmaceuticals Holding
Corp. (NASDAQ: TNXP):
Tonix is a clinical-stage biopharmaceutical
company focused on discovering, licensing, acquiring and developing
small molecules and biologics to treat and prevent human disease
and alleviate suffering. Tonix's portfolio is primarily composed of
the central nervous system (CNS) and immunology product candidates.
The CNS portfolio includes both small molecules and biologics to
treat pain, neurologic, psychiatric and addiction conditions.
Tonix's lead CNS candidate, TNX-102 SL1, is in mid-Phase 3
developments for the management of fibromyalgia, and positive data
on the RELIEF Phase 3 trial were recently reported. The Company
expects interim data from a second Phase 3 study, RALLY, in the
third quarter of 20212 and top-line data in the fourth quarter
of 2021. The immunology portfolio includes vaccines to prevent
infectious diseases and biologics to address immunosuppression,
cancer, and autoimmune diseases. Tonix's lead vaccine candidate,
TNX-18003, is a live replicating vaccine based on the horsepox
viral vector platform to protect against COVID-19, primarily by
eliciting a T cell response. Tonix reported positive efficacy data
from animal studies of TNX-1800 in the first quarter of 2021.
TNX-801, live horsepox virus vaccine for percutaneous
administration, is in development to protect against smallpox and
monkeypox – www.tonixpharma.com.
1TNX-102 SL is an investigational new drug and has
not been approved for any indication. 2Pending agreement from FDA
on statistical analysis plan
About Artificial Intelligence Technology
Solutions (OTCPink:AITX):
AITX is an innovator in the delivery of artificial
intelligence-based solutions that empower organizations to gain new
insight, solve complex challenges and fuel new business ideas.
Through its next-generation robotic product offerings, AITX’s RAD
and RAD-M companies help organizations streamline operations,
increase ROI and strengthen business. AITX technology improves the
simplicity and economics of patrolling and guard services, and
allows experienced personnel to focus on more strategic tasks.
Customers augment the capabilities of existing staffs and gain
higher levels of situational awareness, all at drastically reduced
cost. AITX solutions are well suited for use in multiple industries
such as enterprises, government, transportation, critical
infrastructure, education and healthcare. To learn more,
visit www.aitx.ai and www.roboticassistancedevices.com,
or follow Steve Reinharz on Twitter @SteveReinharz.
About HeliosDx (RushNet, Inc)
(OTCPink: RSHN):
heliosDX (OTCPink: RSHN) is a National Clinical
Reference Laboratory offering High-Complexity Urine Drug Testing
(UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids,
Infectious Disease (PCR), and NGS Genetic Testing. The Company is
contracted in 44 of the lower 48 states, and looking to expand its
reach and capabilities. The Company continually invests in its
infrastructure with the most efficient scientific proven
instruments, and latest cutting-edge software for patient and
physician satisfaction. This allows heliosDX to provide physicians
fast and accurate reporting meeting and exceeding industry
benchmarks. heliosDX excels in patient and client care through
physician designed panels that aid in testing compliance and
reporting education- https://heliosdx.com/.
About GlobeX Data Ltd. (OTCQB:SWISF)
(CSE:SWIS) (FRA:GDT):
GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS)
(FRA:GDT) is a Cybersecurity and Internet Privacy provider of
Swiss hosted solutions for secure communications and secure data
management. The Company distributes a suite of secure messaging
applications, encrypted e-mails, secure communications and secure
data management tools, using Swiss privacy laws, proprietary
technology and its own independent platform, away from big tech's
hosting platforms. GlobeX Data Ltd. sells its products through its
approved wholesalers and distributors, and telecommunications
companies worldwide. GlobeX Data Ltd. serves consumers, businesses
and governments worldwide
- https://globexdata.com. Sekur® is a Swiss
secure communications application offering secure and private
messaging, emails, voice messages, self-deleting messages, and file
transfers from any mobile device, tablet, or desktop. Sekur users
can communicate with Sekur and with non-Sekur users, through its
unique Chat-By-Invites feature and SekurSend email system. All data
traffic stay in GlobeX Data's Swiss hosted servers, using its
proprietary HeliX technology, military grade encryption and
benefiting from Swiss Privacy Laws
– https://sekur.com. Twitter:
@globexdata.
About First Graphene Ltd
(OTCQB: FGPHF) (ASX: FGR):
First Graphene Ltd (OTCQB: FGPHF)
(ASX: FGR) is the leading supplier of
high-performing, graphene products. The company has a robust
manufacturing platform based upon captive supply of high-purity raw
materials and an established 100 tonne/year graphene production
capacity. Commercial applications are now being progressed in
composites, elastomers, fire retardancy, construction and energy
storage. PureGRAPH® Range of Products PureGRAPH® graphene powders
are available in tonnage volumes with lateral platelet sizes of
50μm, 20μm, 10μm and 5μm. The products are high performing
additives, characterized by their high quality and ease of use.
First Graphene Ltd. is publicly listed on the OTC MARKETS (OTCQB:
FGPHF) and on the Australia Stock Exchange (ASX:FGR).
About FMW Media: FMW Media
operates one of the longest-running U.S and International sponsored
and Syndicated Nielsen Rated programming T.V. brands "New to the
Street," and its blockchain show "Exploring The Block." Since 2009,
these brands run biographical interview segment shows across major
U.S. Television networks. The TV platforms reach over 540 million
homes both in the US and international markets. FMW recently added
Newsmax to its broadcasting platform with its first show
broadcasted Sunday, December 27th. The NEWSMAX New to The Street
show is syndicated on Sundays at 10 AM EST. FMW is also one of the
nation's largest buyers of linear Television long and short form-
https://www.newsmaxtv.com/Shows/New-to-the-Street
https://www.newtothestreet.com/.
Forward-Looking Statements
Disclaimer:
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. In some cases, you can identify
forward-looking statements by the following words: "anticipate,"
"believe," "continue," "could," "estimate," "expect," "intend,"
"may," "ongoing," "plan," "potential," "predict," "project,"
"should," "will," "would," or the negative of these terms or other
comparable terminology, although not all forward-looking statements
contain these words. Forward-looking statements are not a guarantee
of future performance or results, and will not necessarily be
accurate indications of the times at, or by, which such performance
or results achieved. This press release should be considered in
light of all filings of the Company contained in the Edgar Archives
of the Securities and Exchange Commission at www.sec.gov.
FMW Media Contact: Bryan Johnson +1 (631) 766-7462
Bryan@NewToTheStreet.com
And “New to The Street” Business Development
office Support@NewtoTheStreet.com 1-516-696-5900
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/badafbbc-ae53-4caa-b7d6-9ece173d0365
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
From Apr 2023 to Apr 2024